11 stories in this blend

Biohub, the US Department of Energy, and the NIH pledged $1.8 billion to establish open access biological datasets designed to help AI predict cellular responses to medical treatments. Tech firms including Google DeepMind and Meta contributed an additional $300 million.

Google DeepMind introduced SynthID Bio, a watermarking system that tracks and identifies synthetic proteins designed by AI models. Laboratory experiments showed that embedding these digital identifiers did not compromise the biological function of the engineered proteins.

Microsoft Research partnered with pharmaceutical firms GSK and Novartis to launch RetroChimera, an AI system trained on drug discovery data. The model demonstrates improved predictions for synthesized molecular structures using proprietary and open research datasets.

A clinical participant affected by severe speech loss used a Neuralink brain chip to generate spoken sentences directly from thoughts. The device converted his brain signals to vocalize personal messages to his family.

Scientists uncovered an ancient gene editing mechanism named VIPR that originated over 4 billion years ago. Utilizing smaller proteins than CRISPR, VIPR could offer broader genome targeting and easier therapeutic delivery into human cells.

A research group transplanted laboratory grown human brain tissue into mice lacking a cortex, creating animals with millions of active human neurons. Initial cognitive and physical evaluations show the subjects continue to exhibit standard mouse behaviors.

Insilico Medicine launched a research initiative utilizing artificial intelligence to design cellular treatments for age related conditions. The process uses machine learning to identify surface targets on aging immune cells and delivers circular RNA instructions to direct cellular removal.

Scientists developed a new antivenom candidate by isolating protective proteins that rattlesnakes naturally produce against their own venom. Lab experiments revealed the mixture was significantly more effective than traditional treatments across various viper species.

Google DeepMind has introduced AlphaGenome Atlas, a comprehensive database that maps potential DNA single-letter variations across the human genome. Medical researchers are using the tool to locate subtle genetic mutations connected to rare conditions that standard genetic scans missed.

Scientists in China developed engineered muscle grafts that contract autonomously without requiring neural activity. In animal trials, the self-activating tissues helped maintain bone density, physical endurance, and muscle volume. The innovation is intended to help bedridden or elderly individuals who cannot perform physical exercise.

Researchers utilized artificial intelligence to redesign key genetic sequences previously shown to reverse cellular damage in sight impaired mice. The computer generated gene variants achieved fifty times higher efficacy than the natural versions discovered over prior decades of manual biological research.